Health professionals advise pregnant women, especially expectant mothers, that they should avoid taking medication or supplements during pregnancy without first consulting their doctors. Until recently, Tylenol (and generic acetaminophen) have been considered safe pain relievers and fever reducers for women during pregnancy. Acetaminophen relieves pain and is widely used, but recent acetaminophen lawsuits have raised questions about its safety during pregnancy, particularly regarding the risk to unborn children and their health.
Unfortunately, a growing body of scientific research has identified an association between prenatal acetaminophen exposure and an increased risk of autism spectrum disorder (ASD) and ADHD. For example, a study published in JAMA Psychiatry in 2020 found that in-utero acetaminophen exposure was associated with an increased risk of both conditions in a cohort of 996 mother-infant pairs. These and other epidemiological studies now form the foundation of the pending litigation.
As a result, hundreds of Tylenol lawsuit claims and acetaminophen lawsuits have been filed against Johnson & Johnson and various generic retailers selling acetaminophen products, targeting Tylenol’s manufacturers and retailers for the harm caused to children due to acetaminophen usage during pregnancy. These product liability lawsuits focus on allegations that acetaminophen labels failed to warn about potential risks and include Tylenol lawsuits filed as part of multidistrict litigation and class action lawsuits.
The team of Tylenol Autism Lawsuit lawyers at Lawsuit Legal News (LLN) is committed to seeking justice for injury victims who were exposed to acetaminophen in utero and their families. Families deserve complete and accurate information about any potential risks associated with medications used during pregnancy so they can make informed healthcare decisions.
The central issue in these lawsuits is whether the scientific evidence meets the legal threshold for proving that acetaminophen causes neurodevelopmental disorders, rather than just being associated with them.
The Tylenol autism litigation continues to evolve as new scientific research, court rulings, and legal developments shape the future of these cases.
If you're wondering whether the Tylenol autism lawsuit is still active, whether you qualify to file a claim, or what has happened in the litigation, the information below explains everything you need to know.
- MDL No. 3043 was centralized in the Southern District of New York under Judge Denise Cote, consolidating hundreds of federal Tylenol autism lawsuits.
- The lawsuits allege that prenatal exposure to Tylenol (acetaminophen) increased the risk of autism spectrum disorder (ASD), ADHD, and other neurodevelopmental disorders.
- Defendants include Johnson & Johnson, major retailers (including Walmart, CVS, Walgreens, Costco, and Rite Aid), and generic acetaminophen manufacturers.
- As of July 2026, the federal Tylenol autism lawsuits are active once again after the U.S. Court of Appeals for the Second Circuit revived more than 500 previously dismissed cases.
- The federal MDL will now return to the district court for additional proceedings.
- Plaintiffs must still prove through admissible expert testimony that prenatal acetaminophen exposure can cause autism and ADHD.
- State court Tylenol autism lawsuits continue moving forward alongside the revived federal litigation.
- Children diagnosed with autism spectrum disorder (ASD) after in-utero exposure to acetaminophen may be entitled to compensation for medical expenses, therapy, specialized education, lost parental income, and pain and suffering.
- Children diagnosed with ADHD or other neurodevelopmental disorders after prenatal acetaminophen exposure may also qualify to file a claim.
- On October 5, 2022, the Judicial Panel on Multidistrict Litigation created MDL No. 3043 to coordinate federal Tylenol autism lawsuits.
- In December 2023, Judge Denise Cote excluded the plaintiffs' general causation experts, resulting in the dismissal of the federal MDL.
- Plaintiffs contend the defendants failed to warn pregnant women about the potential neurodevelopmental risks associated with prolonged acetaminophen use during pregnancy despite growing scientific evidence.
- Defendants argue that the available scientific evidence demonstrates only an association—not causation—and maintain that the warnings on their products complied with federal law.
If you believe your family has been affected, contact our team for a free, no-obligation case review to learn whether you may qualify to file a Tylenol autism lawsuit.
Tylenol Lawsuit: Protect Your Child's Rights After an Autism Diagnosis
If your child was exposed to Tylenol during pregnancy and later diagnosed with autism, ADHD, or another neurodevelopmental condition, turn to the skilled lawyers at LLN to learn all about your rights. Our team has represented over 40,000 injured clients and helped them recover over $400 million to compensate for their losses.
The award-winning attorneys at LLN have 120 years of combined experience, and we are currently handling several Tylenol autism lawsuits on behalf of innocent families who had no idea that taking acetaminophen during pregnancy could lead to autism. Reach out today to learn more about your legal rights and what you can do next.
Following the Second Circuit's July 2026 decision reviving the federal Tylenol lawsuits, our team continues to help families understand their legal options while closely monitoring developments in the litigation. We are also assisting families whose children were diagnosed with autism after consuming certain toxic baby foods. Contact our legal team to learn more about both types of claims and whether your family may qualify.
Is the Tylenol Autism Lawsuit Still Active?
Yes. As of July 2026, the Tylenol autism lawsuit is active once again after the U.S. Court of Appeals for the Second Circuit revived more than 500 federal lawsuits that had previously been dismissed.
The federal multidistrict litigation (MDL) was temporarily halted after Judge Denise Cote excluded the plaintiffs' general causation experts under the Daubert standard. Without expert testimony linking prenatal acetaminophen exposure to autism spectrum disorder (ASD) and ADHD, the court concluded the plaintiffs could not move forward with their claims.
However, the Second Circuit unanimously reversed much of that decision, holding that the district court applied the wrong legal standard when evaluating three of the plaintiffs' expert witnesses. Rather than deciding whether the experts' conclusions were ultimately correct, the appeals court explained that the proper question was whether the experts relied on scientifically reliable methods to reach their opinions.
As a result, the federal litigation is moving forward once again. The lawsuits have been sent back to the district court for additional proceedings, where the admissibility of the plaintiffs' expert testimony will be reconsidered under the correct legal standard.
The appeals court did not rule that Tylenol causes autism or ADHD, nor did it determine that Johnson & Johnson or the other defendants are liable. Instead, the decision gives plaintiffs another opportunity to present their scientific evidence and continue pursuing their claims in federal court.
While the federal appeal was pending, Tylenol autism lawsuits also continued to move forward in several state courts, including Florida, Illinois, Pennsylvania, and Texas. The litigation has continued to expand even during the MDL's temporary dismissal.
Below is a timeline of the most significant developments shaping the Tylenol autism litigation, including the Second Circuit's landmark July 13, 2026 decision.
Tylenol Autism Lawsuit Updates 2026
Here is the latest information on the Tylenol autism lawsuit. We regularly update this page as new court decisions, scientific developments, and litigation milestones occur.
July 13, 2026 – Important Update: Federal Appeals Court Revives More Than 500 Tylenol Autism Lawsuits
In a major victory for families pursuing Tylenol autism claims, the U.S. Court of Appeals for the Second Circuit unanimously reversed Judge Denise Cote's decision dismissing more than 500 federal lawsuits.
The appellate court ruled that Judge Cote applied the wrong legal standard when she excluded three of the plaintiffs' general causation experts under the Daubert standard. Rather than deciding whether the experts' conclusions were ultimately correct, the appeals court explained that the trial court should have focused on whether the experts used reliable scientific methods to reach their opinions.
As a result, the federal litigation is officially back on track. The lawsuits will now return to the district court for additional proceedings, allowing plaintiffs another opportunity to prove that prenatal acetaminophen exposure can cause autism spectrum disorder (ASD) and ADHD.
This decision does not mean the plaintiffs have won the litigation or that Tylenol has been found to cause autism. However, it significantly changes the trajectory of the litigation and gives hundreds of families another opportunity to pursue compensation.
March 10, 2026 – State Court Lawsuits Continue to Expand
While the federal appeal remained pending, new Tylenol autism lawsuits continued to be filed in several state courts, including Florida, Illinois, and Pennsylvania. Many attorneys chose to continue pursuing claims outside the federal MDL while waiting for the Second Circuit's decision.
December 2025 – Second Circuit Signals Concerns During Oral Arguments
During oral arguments, members of the Second Circuit questioned whether Judge Cote improperly evaluated the credibility of the plaintiffs' experts rather than limiting her review to whether the experts relied on scientifically accepted methodologies. Those questions foreshadowed the appellate court's July 2026 decision.
September 2024 – Plaintiffs Appeal Federal Dismissal
After Judge Cote dismissed the federal litigation based on her exclusion of the plaintiffs' expert testimony, the plaintiffs appealed to the U.S. Court of Appeals for the Second Circuit, arguing that the trial court applied the Daubert standard too aggressively.
December 2023 – Judge Excludes Plaintiffs' Expert Witnesses
Following lengthy Daubert proceedings, Judge Denise Cote excluded all of the plaintiffs' primary general causation experts. Without expert testimony establishing that acetaminophen can cause autism or ADHD, the federal lawsuits could not proceed.
October 5, 2022 – Federal Tylenol MDL Created
The Judicial Panel on Multidistrict Litigation created MDL No. 3043 in the Southern District of New York, consolidating hundreds of lawsuits alleging that prenatal exposure to Tylenol and generic acetaminophen increased children's risk of developing autism spectrum disorder and ADHD.
September 2021 – Medical Consensus Statement Published
Ninety-one scientists, clinicians, and public health professionals published a consensus statement in Nature Reviews Endocrinology urging pregnant women to exercise caution when using acetaminophen. The statement cited growing evidence linking prolonged prenatal acetaminophen exposure to neurodevelopmental disorders and became one of the most widely discussed publications in the litigation.
Does Tylenol Cause Children to Develop Autism Spectrum Disorder (ASD)?
Acetaminophen has long been the primary recommended pain and fever reliever for pregnant individuals. However, growing safety concerns have left many consumers uncertain.
Multiple scientific studies suggest that acetaminophen exposure during pregnancy may increase the risk of autism spectrum disorder (ASD), Attention Deficit Hyperactivity Disorder (ADHD), or other developmental disorders.
A study published in JAMA Psychiatry in 2020 found a link between in-utero acetaminophen exposure and an increased risk of ASD and ADHD, based on a cohort of 996 mother-infant pairs.
The plaintiffs in the Tylenol autism lawsuits maintain that the primary manufacturer and major retailers knew or should have known about emerging epidemiological studies on neurodevelopmental risks and failed to update warning labels, especially regarding a child's risk of developmental disorders.
The legal theory presented is that the failure to warn about health risks has resulted in harm to their children.
Additionally, a Johns Hopkins study found that children with the highest levels of acetaminophen in their cord blood were almost three times more likely to be diagnosed with autism compared to those with the lowest levels.
While multiple studies have found an association between prenatal acetaminophen exposure and an increased risk of autism and ADHD, the legal question is whether that evidence is strong enough to establish causation under the rules governing expert testimony. The Second Circuit's July 2026 decision did not determine that Tylenol causes autism. Instead, it ruled that the plaintiffs' experts should have another opportunity to present their opinions under the proper legal standard, allowing the litigation to move forward.
Find Out If You Qualify for a Baby Food Autism Lawsuit or Tylenol Autism Lawsuit Today!
Tylenol and Autism Spectrum Disorder: The Research Linking the Two
Tylenol (acetaminophen) is a pain reliever commonly used to reduce fever and relieve mild to moderate pain. Estimates show that 65% of pregnant women in the United States have used acetaminophen while pregnant.
Although this pain relief drug is generally considered safe, we now know unborn children and fetuses are particularly vulnerable to the chemically active substances that can impact their development.
Currently, the scientific community is amassing more and more evidence that suggests Tylenol-linked exposure during pregnancy is associated with an increased risk that the child will develop autism spectrum disorder (ASD) or another developmental disorder. A 2018 study conducted among 132,738 mother and child pairs over several years indicated a 20% increased risk of autism and a 30% higher risk of ADHD after prolonged exposure to acetaminophen.
Potential adverse outcomes of acetaminophen use during pregnancy include:
Autism Spectrum Disorder and ADHD
Multiple studies now draw a connection between Tylenol, autism, ADHD, and the propensity to develop one or more of these conditions following fetal exposure. In data from the Boston Birth Cohort study, umbilical cord blood samples revealed a correlation between Tylenol usage and neurological disorders. Doctors diagnosed 25.8% of children who were exposed to the drug with ADHD and 6.6% with an autism spectrum disorder.
Hormonal and Genital Abnormalities
The active ingredient in Tylenol is considered an endocrine disruptor, meaning it can interfere with normal hormonal processes involved in healthy development. Research suggests that depleted hormones can lead to unexpected consequences in babies who received prenatal exposure to Tylenol or generic acetaminophen.
These include genital deformities at birth, which some studies discuss as potential birth defects linked to prenatal acetaminophen exposure, as well as low sperm count in boys or early puberty in girls.
Lowered IQ and Behavioral Issues
Research has found that acetaminophen exposure during pregnancy seems to correlate with a lower IQ score in young children. Research has also linked Tylenol exposure in pregnant women to greater social difficulties, such as emotional and conduct problems, in their children.
Long-Term Effects of Tylenol Use During Pregnancy
Autism spectrum disorder is a complex developmental disorder that can affect an individual's ability to learn, socialize, and work. These issues can affect both the person with ASD and their family or caregivers, often at a steep economic cost.
For example, your child may have specialized medical or psychiatric needs and require regular visits to see healthcare practitioners or therapists.
A child diagnosed with autism spectrum disorder who needs routine special care may require a parent to put aside other duties or job opportunities to meet their needs. School-age children with autism or attention deficit hyperactivity disorder may require special tutoring to advance. They may also require therapy and medication to address these conditions' emotional difficulties.
Symptoms of autism spectrum disorder may include:
- Difficulty with social skills
- Delayed language skills
- Understanding expectations in school or the workplace
- Unusual mood changes or emotional reactions
In addition to these common ASD symptoms, autism spectrum disorder can also bring about a higher incidence of co-morbidity with anxiety, depression, and certain neurological disorders. In some instances, the severity of the condition may cause the affected person to require lifelong care, which comes at great expense.
Keep in mind, the research regarding in utero acetaminophen exposure consistently illustrates that the amount and length of Tylenol use during pregnancy directly relate to the risk of autism.
Symptoms of ADHD may include:
- Hyperactivity
- Difficulty organizing or concentrating
- Excessive physical movement or fidgeting
- Increased risk-taking
These factors can all bring increased stress and economic strain to a family. The associated costs brought on by caring for someone with autism spectrum disorder or ADHD may qualify as legal damages in a Tylenol autism lawsuit.
Your family may recover compensation in an autism/ADHD lawsuit if you can establish a connection to acetaminophen use during pregnancy. Learn how our experienced team of mass tort lawyers can strengthen your claim for financial compensation during a free consultation.
Do You Have a Viable Tylenol Autism Claim?
A dedicated product liability attorney will gather as much medical evidence as possible to prove your child's ASD or ADHD diagnosis is connected to acetaminophen use during pregnancy. Usually, this will involve requesting copies of medical records from the time of the pregnancy. Additional information, such as receipts and purchase history, can also confirm prolonged exposure to Tylenol.
Your attorney will guide you through the process of proving Tylenol use during pregnancy and ensure that all relevant evidence is properly presented to support your claim. Keep in mind that numerous studies have demonstrated a correlation between the use of acetaminophen while pregnant and an increased risk of autism spectrum disorder diagnosis.
Throughout the studies, we note that higher levels of acetaminophen exposure equate to higher rates of autism. In fact, autism rates nearly mimic the levels of exposure, demonstrating a dose-dependent relationship in multiple published peer-reviewed studies. Further, numerous confounding factors were accounted for in demonstrating an elevated risk for autism.
How Much Can You Recover in a Tylenol Autism Lawsuit?
Projected settlement values in Tylenol autism lawsuits are still being analyzed and reviewed according to the relevant data available and the outcomes of other prior mass tort cases. Individual values will likely depend heavily on the severity of the autism.
Autism Spectrum Disorder is classified into three main categories. ASD 1 is the least severe manifestation of the disorder, and ASD 3 is the most severe. Early settlement projections suggest the following potential values for ASD-level claims in acetaminophen autism lawsuits:
- ASD Level 1: $150,000 to $225,000
- ASD Level 2: $250,000 to $500,000
- ASD Level 3: Exceeding $500,000
Your potential settlement amount will vary depending on the amount of your economic and non-economic damages. Your unique financial losses may include pain and suffering, lost wages, and medical expenses, among others. When you partner with a skilled mass tort attorney at LLN, they can work with you to ensure that you receive the maximum compensation available and create a solid legal strategy that will strengthen your claim.
Is There an Autism Class Action Lawsuit Against Tylenol?
Class action lawsuits involve multiple plaintiffs suffering the same injuries,ee bringing suit against the same defendant or defendants. While some refer to the ongoing litigation as the 'Tylenol autism class action' or 'Tylenol class action lawsuit,' Tylenol autism lawsuits do not technically qualify as a class action because the plaintiffs are claiming a variety of injuries with varying degrees of severity, and the defendants are not necessarily the same.
So because the defendant is the same but the injuries and damages are vastly different, these cases are being handled as federal Tylenol lawsuits, which are coordinated due to the large number of similar claims filed nationwide. However, since so many lawsuits have been filed by injured plaintiffs around the country, the federal court system adopted a different strategy.
Instead of forming a class action, a multi-district litigation (MDL) has been created to coordinate pre-trial discovery and motion hearings. This MDL consolidates acetaminophen lawsuits, including those alleging that prenatal exposure to Tylenol is linked to autism and ADHD. A Tylenol MDL ensures more efficient legal proceedings and consistent rulings across the nation. In general, the complaints claim that prenatal use of acetaminophen inhibits fetal brain development and increases the risk of autism spectrum diagnosis.
Tylenol Autism and ADHD Lawsuit MDL Update
Once the Judicial Panel on Multidistrict Litigation (JPML) consolidated the federal lawsuits, all Tylenol autism and ADHD claims filed in U.S. District Courts nationwide were transferred before Judge Denise Cote in the United States District Court for the Southern District of New York. The Tylenol autism MDL was centralized there to coordinate the federal proceedings.
This multidistrict litigation process allows the parties to streamline discovery, avoid duplicative litigation, and handle common legal and scientific issues more efficiently.
The defendants named in the Tylenol MDL include major retailers that sold Tylenol and generic acetaminophen products, including Walmart, CVS, Walgreens, Costco, and Rite Aid. In June 2023, Family Dollar, Dollar Tree, and 7-Eleven were also added as defendants.
The lawsuits additionally target drug manufacturers, including Johnson & Johnson, which distributes the medication under the Tylenol brand name.
The lawsuits allege that manufacturers and retailers ignored growing warnings from health professionals and failed to adequately warn consumers about the potential risks associated with prenatal acetaminophen exposure. Plaintiffs argue families were not properly informed about the alleged connection between Tylenol use during pregnancy and autism spectrum disorder (ASD) or ADHD diagnoses in children.
In many mass tort cases, drug manufacturers aggressively defend these lawsuits instead of quickly settling them. Retailers, however, may face additional public pressure because of concerns about consumer trust and brand reputation.
If you believe your child’s autism or ADHD diagnosis may be linked to prenatal Tylenol exposure, our law firm can review your case, evaluate potential compensable damages, and help determine whether you may qualify to file a Tylenol lawsuit.
How Can Our Mass Tort Attorneys Recover Compensation For You?
Our experienced mass tort attorneys can assist at every stage of your Tylenol autism or ADHD lawsuit. Our legal team can gather evidence, build your case, and develop a strategy to support your claim to help you recover the maximum compensation possible.
With our skilled lawyers fighting for you, you may receive compensation for economic and non-economic damages due to Tylenol or generic acetaminophen exposure, including:
- Medical expenses and future treatment costs
- Pain and suffering
- Emotional distress
- Loss of quality of life
- Lost wages or income
- Permanent disability
- Lifelong personal care and shelter
We are committed to ensuring that our clients can pursue the best course of action to benefit them emotionally and financially. Throughout the lifecycle of your case, we will do our utmost to ensure that you understand your options, answer your questions, and prove that you can depend on us to guide you through the legal process.
Understanding the Tylenol Autism MDL
The Tylenol autism lawsuits are being coordinated through MDL No. 3043 in the Southern District of New York. Although the federal litigation was temporarily dismissed after Judge Denise Cote excluded the plaintiffs' expert testimony, the Second Circuit Court of Appeals revived more than 500 lawsuits in July 2026.
The litigation will now return to the district court, where the admissibility of the plaintiffs' expert evidence will be reconsidered under the legal standard established by the appellate court. Unlike a class action, each family maintains its own individual lawsuit within the MDL while sharing common discovery and scientific issues with other plaintiffs.
The purpose of the MDL is to efficiently resolve common legal and scientific issues shared by hundreds of individual lawsuits while allowing each family to pursue compensation based on its own unique circumstances. As the litigation moves forward following the Second Circuit's July 2026 decision, the district court will continue addressing expert testimony and other pretrial issues before additional cases can proceed.
Our legal team can assess your specific potential damages and help determine the value of your claim against Tylenol's manufacturers and retailers in relation to your child's autism diagnosis.
Can I Still File a Tylenol Autism Lawsuit?
Yes. Following the Second Circuit's July 13, 2026 decision reviving more than 500 previously dismissed federal lawsuits, families may still be eligible to file a Tylenol autism lawsuit. In addition to the revived federal MDL, Tylenol autism lawsuits continue to be filed in state courts across the country.
Whether you still have time to file depends on several factors, including where you live, when your child was diagnosed, and your state's statute of limitations. Some states also recognize legal exceptions that can extend filing deadlines in certain situations. Because these rules vary from state to state, it is important to speak with an attorney as soon as possible rather than assume it is too late.
Even if you are unsure whether your family qualifies, it is worth having your case reviewed. An experienced product liability attorney can evaluate your circumstances, explain your legal options, and determine whether you may be eligible to pursue compensation for your child's autism spectrum disorder (ASD), ADHD, or other neurodevelopmental condition.
Even if you are uncertain whether you qualify, speaking with an attorney sooner rather than later can help preserve your legal rights. There is no obligation to move forward after a consultation, but waiting too long could affect your ability to bring a claim.
If you believe prenatal exposure to Tylenol or generic acetaminophen may have contributed to your child's diagnosis, our legal team can review your case at no cost and help you understand your next steps.
We are Tylenol Autism Lawyers You Can Trust
We understand the confusion and distress that may arise from discovering that a commonly used household pain reliever could be linked to your child's significant health issues. The difficulties of diagnosing autism spectrum disorder and ADHD in early life mean that you may have endured years of hardship without understanding the potential connection to acetaminophen use during pregnancy.
If prenatal Tylenol use injured you or someone you love, you have legal rights and may be able to seek reparations. Our legal team is committed to standing up for the rights of injury victims. We have the experience and tenacity to navigate the most complex cases and the resources to take on the pharmaceutical giants and corporate retailers responsible for your losses.
Our legal team has closely followed the Tylenol autism litigation from its earliest stages and continues to monitor every significant scientific study, court ruling, and litigation development. We believe families deserve clear, accurate information and experienced legal guidance while these cases continue to move through the courts.
Don't wait any longer, call 866-535-9515 or submit your case for review today!
Reach out to Lawsuit Legal News to Discuss Your Tylenol Autism Lawsuit
Our attorneys are committed to seeking justice for injury victims, including families affected by prenatal acetaminophen exposure. Backed by a nationally recognized personal injury and mass tort litigation team with experience handling complex pharmaceutical and product liability claims, we closely follow the evolving scientific research and legal developments surrounding Tylenol autism and ADHD lawsuits.
We strongly believe families deserve answers, accountability, and the opportunity to pursue compensation when corporations allegedly fail to provide adequate safety warnings. Our legal team is prepared to take the necessary legal steps to protect those affected and fight for the justice that injured children and their families deserve.
If someone you love was diagnosed with one of these neurodevelopmental disorders after prenatal exposure to Tylenol, we implore you to reach out to us for a free consultation and case review. We offer a free case review to assess your eligibility for a Tylenol autism lawsuit; there is no cost or obligation. Call 866-535-9515 today or complete our online contact form.